Pacific Biosciences of California PACB Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.01M-53.3% | $2.77M-31.9% | $3M-56.5% | $4.7M-22.6% | $4.29M-36.5% | ||
| $45.8M— | —— | —— | —— | $0— | ||
| -$8.28M+98.1% | -$40.37M— | -$38M+37.4% | -$41.93M+75.8% | -$426.08M-445% | ||
| $0-100% | $11K— | $75K— | $24K-97.6% | $4.07M— | ||
| $833K-99.8% | $833K-82.0% | $833K-77.2% | $833K-80.3% | $362.04M+6,475% | ||
| $15.4M— | —— | —— | —— | $0— | ||
| $1.02M-99.7% | $1.02M-85.1% | $1.02M-85.1% | $1.02M-85.1% | $366.39M+5,246% | ||
| $0+100% | $0+100% | $0-100% | $0— | -$18.7M-26,614% | ||
| $2.2M-57.1% | $2.74M-3.7% | $2.46M-41.3% | $2.66M-24.0% | $5.13M+58.4% | ||
| $45.8M— | —— | —— | —— | $0— | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $0-100% | $0— | $0— | $0-100% | $15M— | ||
| -$4.32M-183% | $1.72M-52.6% | $1.27M+123% | $1.02M— | -$1.53M-123% | ||
| -$6.1M-248% | $4.83M+360% | —— | $612K— | $4.12M+165% | ||
| $314K+1.0% | $4.55M— | $1.01M+130% | -$2.72M— | $311K+101% | ||
| $3.21M+26.3% | —— | $1.06M— | $1.33M-74.0% | $2.54M-78.2% | ||
| $2.29M+167% | -$717K— | -$988K— | -$3.38M-566% | -$3.43M-12.3% | ||
| —— | $2.07M-44.2% | $2.07M-44.2% | $2.07M-44.2% | $2.07M-44.2% | ||
| $1.44M-26.6% | —— | $1.47M+80.9% | —— | $1.96M-70.1% | ||
| $35.86M-20.7% | $26.03M-55.3% | $18.9M-18.0% | $25.28M-67.1% | $45.23M+233% | ||
| -$44.69M-1.4% | -$19.07M+37.8% | -$18.71M+58.9% | -$29.38M+45.9% | -$44.06M+41.8% | ||
| $5M0.0% | —— | —— | —— | $5M— | ||
| $52.45M-15.2% | $33.09M-58.9% | $65.83M-42.6% | $56.17M-49.7% | $61.82M-67.8% | ||
| $3.04M+119% | $861K-46.8% | $0— | $550K-62.8% | $1.39M-64.2% | ||
| $48.25M-57.5% | $59.98M-47.2% | $84.64M-34.3% | $82.01M-56.8% | $113.44M-29.8% | ||
| $4.46M-51.5% | $9.59M-40.2% | $10.98M-39.8% | $11.9M-30.9% | $9.2M-52.9% | ||
| -$5.14M+91.1% | -$37.44M+73.9% | -$35.4M+33.3% | -$41.18M+75.1% | -$57.41M+19.4% | ||
| -$8.36M+98.1% | -$41.2M+73.1% | -$38.88M+39.3% | -$44.85M+74.5% | -$428.93M-427% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Pacific Biosciences of California's revenue?
- Pacific Biosciences of California (PACB) generated $160.0M in revenue over the trailing twelve months, up 5.0% year over year.
- Is Pacific Biosciences of California profitable?
- Pacific Biosciences of California is not currently profitable: it reported a net loss of $128.6M over the trailing twelve months, a -80.3% net margin.
- What are Pacific Biosciences of California's profit margins?
- Gross margin is 37.5% and operating margin is -83.3%, with a -80.3% net margin.
- What is Pacific Biosciences of California's earnings per share?
- Pacific Biosciences of California's diluted EPS over the trailing twelve months is $-0.43.
- Where does Pacific Biosciences of California's income statement data come from?
- Every line is extracted from Pacific Biosciences of California's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
